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1. Introduction 
Brachytherapy refers to the delivery of radiation directly into or onto the surface of the area 
to be treated. Radiation sources can be used in body cavities (e.g., the uterus, vagina, 
bronchus, esophagus, and rectum), can be placed on the surface of tumors in the skin or 
may be placed directly into a tissue by interstitial techniques such as those used in the head 
and neck region, prostate, and breast. 
One of the main objectives of brachytherapy is to ensure an accurate and safe dose delivery 
to a target volume while avoiding unnecessary delivery to surrounding healthy tissue. [1] 
In order to ensure the optimal treatment of patients, much effort is required during the 
commissioning phase of new brachytherapy equipment and during its clinical lifetime. 
The institution must therefore develop a suitable Quality Control (QC) program not only 
for brachytherapy sources and equipment but also for the physical and clinical 
procedures. 
In 2000, the IAEA published its Report No. 17 entitled “Lessons learned from accidental 
exposures in radiotherapy”. [2] Although brachytherapy is applied only in about 5% of all 
radiotherapy cases, 32 of the 92 accidents reported in this booklet were related to the use of 
brachytherapy sources. Errors in the specification of source activity, dose calculation or the 
quantities and units involved resulted in doses that were up to twice the prescribed dose. 
Some of the accidents were clearly related to human error. The same document 
demonstrates the need for well-designed QC programs for brachytherapy. For the 
conception of such programs, one must consider the consistency in the management of each 
individual treatment, the realization of the clinical prescription, and the control of safe 
execution of the treatment with regard to the patient and to others who may be involved 
with, or exposed to, the sources during treatment. [3, 4] 
As a result of several accidents recently reported involving the use of advanced technology 
in radiation oncology, QC programs involving independent quality audits are also seen as a 
preventive action. [5,6,7,8] 
The consequences of errors that are bound to occur in a radiation oncology clinical 
environment may be caused by the radiation oncologist, physicist, dosimetrist or radiation 
therapist. Of these errors, the most grievous to the patient are the systematic errors made by 
the physicists without his or her perception.  
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Therefore, the type of mistakes made by each staff member is different, as is the magnitude 
of the impact to the patient, as specified below: 
• if a physician makes a mistake, it usually affects one patient;  
• if a dosimetrist makes a mistake, it affects one patient or one tumor location; 
• if a technologist makes a mistake, it normally affects one fraction of the treatment;  
• if a physicist makes a mistake, it may affect all patients in the clinic during a given 
period of time. 
A sound QC program must be in place to reveal and prevent these mistakes and may 
include as an important component independent Quality Audits. 
2. The brachytherapy technology 
During the past 15 years, high dose rate 192Ir sources have become available as an efficient 
substitute for 137Cs sources. Several advantages have drawn attention to this new technique, 
among which are the possibility to treat several new clinical sites due to the small dimension 
of the source, the viability of out-patients treatment, the lesser number of treatment sessions 
required, the complete remote-controlled source management, which increases the staff 
safety, and a computerized treatment planning system that offers the 3D-volume dose 
calculation. 
 
 
Fig. 1. Typical configuration of commercially available HDR treatment unit  
Since there are several types of HDR sources available in the market, Table 1 presents some 
of the main physical characteristics that are useful for entry-independent calculation 
analytical and numerical calculation methods.  
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Model: 
Active 
length 
Active 
diameter
Total 
diameter
Distance from 
active edge to tip of 
the source 
Encapsulation 
MicroSelectron 
Nucletron 
(new design) 
3.6 0.65 0.9 0.2 Stainless steel 
VariSource 10 0.35 0.61 1 Ni-Ti 
Varian 5 0.34 0.59 1 Ni-Ti 
Buchler 1.3 1 1.6 1 Stainless steel 
Gamma Med 
12i 
3.5 0.6 1.1 0.86 Stainless steel 
Gamma Med 
Plus 
3.5 0.6 0.9 0.62 Stainless steel 
BEBIG 3.5 0.6 1.0 0.9 Stainless steel 
Table 1. Specific characteristics of the 192Ir high dose rate sources. Dimensions are in mm. 
Adapted from [3] 
3. Main treatment sites  
High dose rate machines may have clinical indications in the treatment of a variety of 
different organs either as a primary treatment or as a complementary therapy. As a result, 
there are a large number of applicators and accessories designed specifically to fit the 
geometrical needs of each treatment site.  
Among the numerous applications [1] for HD brachytherapy, the three main areas are:  
Prostate: Two techniques are in use: 1. Temporary implants using a stepping 192Ir HDR 
source to deliver large single-dose fractions has gained acceptance with current 
radiobiological models that predict a low [alpha]/[beta] ratio for prostate cancer, and 2. 
Permanent implantation, mainly with small radioactive seeds of 125I  source with a half-life 
of 59 days is a second option. In some centers, the 121Pd is also used. The latter is not in the 
scope of this chapter. 
Breast: Two techniques for partial breast implant irradiation are in use: 1. multicatheter 
brachytherapy is used as a conventional brachytherapy to cover the tumor bed with a 2- or 
3-plane interstitial implant, and 2. the single-catheter technique that uses a new applicator 
marketed as the Mammosite is essentially a single-line flexible HDR afterloading catheter 
with an inflatable balloon at the end. The latter is not in the scope of this chapter. 
Gynecological: This is focused mainly on cancer of the endometrium and cervix using 
specific types of applicators, for instance a ring system that allows multiple source positions 
including in the upper vagina.  
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Fig. 2. Typical set of applicators, accessories, catheters and sleeves used for HDR treatments 
 
 
Fig. 3. Typical examples of a gynecological intracavitary treatment and a 3D-dose 
distribution around it 
4. The scope of the quality control process 
The emphasis in this chapter is to cover the physics aspects of a quality control program for 
HDR brachytherapy and to promote awareness of the tolerances and frequencies of the basic 
tests required. Those tests are based on the likelihood of a malfunction and the seriousness 
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or potential consequences of an unnoticed malfunction that would affect the patients and/or 
to the personnel involved in the clinical procedure if a malfunction occurs and is not 
identified during normal treatment applications. The purpose of the QC program is to 
guarantee that all operational procedures are being performed properly and in accordance 
with the licensing specifications.  
The QC must consider the compliance aspects of planning through a comprehensive 
management plan, documentation of the actual operations, and the monitoring and 
reporting requirements. [8] 
Tolerances and action levels 
Performance within the tolerance level provides an acceptable degree of accuracy in any 
situation.  If performance is outside the action level, it may demand an action to fix the 
situation.   
A quality control test should use appropriate measuring equipment, which must itself have 
been subjected to maintenance and quality control. Irradiation conditions and measuring 
procedures should be designed to be suitable to each task, and they are expected to give the 
best estimate of the particular measured parameter. Because each measurement has an 
associated uncertainty that depends on several factors, the tolerances established must take 
that into account. 
Action levels are related to tolerances but it may afford sufficient flexibility to monitoring 
and adjustment; for example, if a measurement indicates a result between the tolerance and 
action levels, it may be acceptable to allow clinical use to continue until this is confirmed by 
measurement the next day before taking any further action.  
As a normal procedure, the action levels must be activated depending on each particular 
situation, such as; 
• if a daily measurement is within tolerance, no action is required; 
• if the measurement falls between tolerance and action levels, this may be considered 
acceptable until the next daily measurement; 
• if the measurement exceeds the tolerance level, immediate action is necessary and the 
machine may not be used clinically until the problem is corrected and verified by 
measurement; 
• if repeated measurements remain consistently between tolerance and action levels, 
adjustment is required; 
• any measurement that is outside the action level requires immediate investigation and, 
if confirmed, rectification. 
As in general, action levels are set at about twice the tolerance level, while some critical 
parameters may require tolerance and action levels to be set much closer to each other or 
even at the same value.  
Test frequencies must be considered in the context of the acceptable variation during a 
treatment course and also the period of time over which a parameter varies or deteriorates. 
Frequencies may be modified in the light of experience of the performance and stability of a 
given piece of equipment, initially setting a nominal frequency that may be subsequently 
reviewed in the light of observation. As machines get older, this may need further review. 
The staff resources available to undertake the tests may limit what can be checked, which 
may have an effect on the structure of the quality control program. Tests should be designed 
to provide the required information as rapidly as possible with minimal time and 
equipment.  
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Whenever available, quality control protocols developed by national organizations should 
be applied. The following sections provide some examples of parameters, test frequencies, 
and tolerances currently used for different items of radiotherapy equipment. 
For consistency, the values listed are based on the AAPM TG 40 [9 ] and ESTRO [3 ], and in 
some cases, on recently published additional reports on quality control in radiotherapy [10]. 
In any case, those protocols should be referred to for more details and adapted for local 
circumstances. 
5. General concepts 
It is essential that the performance of treatment equipment remain consistent within 
accepted tolerances throughout the clinical life of the equipment, as patient treatments will 
be planned and delivered on the basis of the performance measurements made during the 
equipment acceptance and commissioning tests. 
An ongoing quality control program shall include regular checks beginning as soon as the 
equipment is commissioned. This program should be able to identify departures from 
expected performance and to activate corrective actions, and it shall consider the following 
points:  
• the parameters to be tested and the tests to be performed; 
• the specific equipment to be used to perform the tests; 
• the geometry of the tests; 
• the frequency of the tests; 
• the staff group or individual performing the tests, as well as the 
• individual supervising and responsible for the standards of the tests and for actions that 
he or she may deem necessary if problems are identified; 
• the expected results; 
• the tolerance and action levels; 
• the actions required when the tolerance levels are exceeded 
6. The quality control program  
The organization of a program requires as a foundation that the institution is willing to be 
prepared for organizational rearrangements if needed in order to lay down very clearly the 
duties and responsibilities of each staff member.  
The institutional organization 
It is important to clearly describe not only the general aspects of the institutional position in 
the organization chart, but also the interaction with similar departments, the legal aspects 
and services provided, and the formal delegation of individual tasks to the staff. It is also 
crucial to detail the information flow, scheduling, list of staff members involved in the 
treatment, information given to the patient, and the radiation protection equipment and 
procedures in the treatment area. 
A set of recommendations is proposed to be an integral part the patient file in order to 
promote appropriate treatment, to help the reviewing process. [3]. 
Patient ID, all documents, films, prints, plots provided with treatment, source strength 
matched with its decayed value, identification of the customizing file and source library, 
correct use of magnification factors and source-film distances, the position of sources or 
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applicators on the plots with radiographs compared with treatment (volume) prescription, 
correct use of units for all quantities, correct use of shielding or other correction factors, 
correct use of treatment parameters, such as step size, catheter length, begin- and end points 
along the catheters, consistent use of prescription criterion and optimization routines, 
according to the physician’s intent and the possibilities of the implant geometry, statement 
about the dose uniformity and the dose differentials, dose and dose per fraction clearly 
stated according to prescription, dose to normal structures, high dose areas, constraints 
clearly fulfilled,  identification of position of reference points, patient points, applicator 
points on the plots, match with those measured on the film,  step size, catheter length, dwell 
times on treatment unit according to plan and for subsequent treatments program card, 
stored standards, or equivalent settings matching the first treatment. 
Clinical procedures 
It is of fundamental importance to clearly specify the control points (as described in Table 2) 
related to each of the procedures currently in use, including the procedures for CT and MRI 
imaging acquisition protocols, imaging reconstruction techniques, data transfer to the 
treatment planning system (TPS), dose validation methods involving the patient simulation 
and treatment, the frequency of each test, training, chart rounds, peer review, and incident 
reports.  
 
Item Material and Methods Frequency 
Test of outcome of HDR 
calculation 
Apply the methods developed at the 
institution for specific clinical cases 
each patient 
Treatment protocols All types of applications should be 
described in detail 
each patient 
Standard forms To be developed for each application each patient 
Independent check Ensure that a second person checks the 
work of the first planner 
each patient 
Table 2. Simple guidelines to be considered as part of the design of the treatment 
operational flux for each patient. Adapted from [3] 
Physical procedures 
The control points defined for the QC program shall also include the physical data either 
taken from tables, publications, guidelines, measurements involving the machine acceptance 
and commissioning, source calibration, patient data (protocols for imaging acquisition and 
data entry to the treatment planning system), dose calculation for the patient, dose 
validations or patient chart checks.  
The early detection of errors in the operational process following the steps proposed in 
Table 3 is very important in order to allow the elimination of errors and to promote the 
necessary modification of the routine procedures.  
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Item Material and Methods 
Patient identification All documents, films, prints, plots provided for a 
treatment 
Dose prescription Delivered dose vs. prescribed dose, evaluation of 
uniformity of the dose, location of prescribed dose, dose 
distribution/differentials in dose, begin and end 
positions correctly along the catheter 
Dose to normal structures Identification of the location of high-dose areas, location 
of normal structures and constraints to be fulfilled 
Program identification Identify the algorithms used, version number, shielding 
and correction factors 
Program verification Identify the source strength, step size and tip length 
Transfer of data Identify the correct position of each dwell position, 
dwell time, total time and correct channels 
Table 3. The main sources of detectable errors and preventive actions recommended in 
orderto avoid unnecessary sources of errors. Adapted from [3] 
Safety aspects 
Protection of the patient and the staff is the most important objective to be considered in the 
proper treatment to the patient. One shall consider the physical conditions and the 
calibration certificates of the physics equipment and review the current procedures 
performed, as well as the emergency procedures, drills, source storage disposal issues, 
posting, surveys including the results of the wipe tests and its appropriate register.  
In addition, one must consider items such as electrical interlocks, source exposure indicator 
lights on the after loader, control console, viewing and intercom systems, emergency 
response equipment, radiation monitors, timer accuracy, clock (date and time) in unit’s 
computer and decayed source activity in unit’s computer.[8] 
A set of minimum requirements for specific actions are presented in Table 4, including the 
frequency of verification of the most important parameters related to the safe operation of 
the clinical procedures. 
It is the physicist’s task to inspect the performance history of the system meticulously, using 
the data in the logbook noted during the clinical lifetime of the equipment. 
An important component of safety is the proper training of the staff to deal with unexpected 
situations. The knowledge of the equipment design and its components, including access to 
the emergency knobs, buttons and tools as shown in Fig.4, may help to speed the resolution 
of a particular incident.  
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Description Minimum requirements 
 Test frequency Action level 
Safety systems   
Warning lights Daily/3M* - 
Room monitor Daily/3M* - 
Communication equipment Daily/3M* - 
Emergency stop 3M - 
Treatment interrupt 3M - 
Door interlock W - 
Power loss 3M - 
Applicator and catheter attachment W - 
Obstructed catheter W - 
Integrity of transfer tubes and applicators 3M - 
Timer termination Daily - 
Contamination test A - 
Leakage Radiation A - 
Emergency equipment (forceps, survey meter) Daily/3M* - 
Practicing emergency procedures 6M - 
Hand crank functioning *** A - 
Hand-held monitor 3M/A** - 
   
Physics parameters   
Source calibration SE/3M >5% 
Source position Daily/3M* >2 mm 
Length of treatment tubes 6M >1 mm 
Irradiation timer 6M >1 % 
Date, time and source strength in treatment 
unit 
Daily - 
Transit time effect 3M - 
(3M–quarterly; 6M–biannual; A–annual; SE–source exchange; W=weekly Adapted from [3] 
*Daily checks are assumed to be an implicit part of normal operation and registered in a logbook. ** 
Verify the proper function of the hand-held monitor, e.g., with a known source of radiation. “Action 
level” reflects the upper limit in clinical conditions 
Table 4. Recommended types, frequencies and tolerances of the quality control tests. 
Adapted from [3] 
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Fig. 4. An inside view of one of the machines available on the market illustrating a manual 
system to retrieve the source and the battery back-up that keeps the equipment operational 
in case of a power failure 
7. Dose calculation 
The dose calculation algorithm of the treatment planning systems uses the TG 43 data 
[11,12], which is the best approach at the present time. This step should include a review of 
the patient identification data, the imaging acquisition protocols, the data transfer to the TPS 
and the results of the independent checks. 
Two important steps must be considered to validate and periodically control this parameter; 
first, the basic dose calculation steps as described in Table 5, and second, the dose volume 
histograms, including optimization, as shown in Table 6. Both tables contain parameters of 
significant relevance to allow a correct clinical decision for treatment and long term  
follow-up.  
In brachytherapy, it is not redundant to reinforce that the concept of recommended 
tolerance levels should be interpreted such that when the tolerance level is reached, it is 
essential that appropriate actions be taken.  
By all means, the treatment unit should not be used clinically when the tolerance level is 
exceeded unless after careful consideration by the medical physicist and with the agreement 
of the radiation oncologists and radiation technologists, a joint decision is made to carry on.  
For medical physicists in this position, it is essential that they possess the awareness and 
skills necessary to make a sound judgment based on all available information and following 
an appropriate assessment of the risks involved. This type of approach may also help with a 
better understanding the concept of tolerance levels. 
www.intechopen.com
The Need for Quality Control in High Dose Rate Brachytherapy 
 
21 
Item Material Frequency 
   
Point dose calculation Identify relevant dose points 
around the source for which a 
dose rate table is available, 
compare results, tolerance level 
is at ±2%, analyze in detail if 
deviations are > 5% 
Initially and with 
software updates 
Source selection Check that the system performs 
the source selection from the 
library properly 
Initially and with 
software updates 
Check dose distribution 
calculated by TPS 
Clinical benchmark cases shall 
be used 
Initially and with 
software updates 
Check dose distribution 
calculated by TPS of 
multiple source geometries 
Compare with previously 
selected clinical benchmark 
cases 
Initially and with 
software updates 
Shielding Check dose distribution of 
sources near the applicator 
shielding 
Initially and with 
software updates 
Table 5. The main steps involved in control of the basic dose calculations 
 
Item Material Frequency 
Volume calculation from 
 3-D imaging data 
Calculate the volume of 
well-defined  “organs”  
Initially and with 
software updates 
DVH of an isotropic point source 
 
 
 
Cumulative differential 
and natural dose 
volume histograms 
Initially and with 
software updates 
Anisotropic sources 
 
 
 
Calculate the DVHs 
with anisotropy 
correction 
Initially and with 
software updates 
Clinical examples Calculate DVHs for  
 benchmark clinical 
cases 
Initially and with 
software updates 
Table 6. The critical parameters related to dose volume histograms and their optimization. 
Adapted from [3] 
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• Treatment-planning system 
In addition to the computer itself, the major hardware devices associated with a planning 
system are the digitizer and the plotter. Their accuracy should simply be routinely checked 
with a benchmark case that checks the overall accuracy of source reconstruction, including 
translation from film to Cartesian coordinates, rotations, and corrections for magnification. 
[13,14]. 
The frequencies should follow those described in Table 9.7  
• The consistency between quantities and units 
A main source of error in dose distribution calculations is the incorrect use of quantities and 
units required by the dose calculation software. It is essential to verify the correct labeling of 
the input and output quantities and units. The strength of the sources (activity) may be 
specified in one of several alternative units, and the user should pay particular attention to 
this important parameter. Inconsistent use of units could lead to severe errors in the 
treatment and possibly compromise the expected treatment outcome. 
• Computer versus manual dose calculation for a single source 
The computer-calculated dose distribution around one linear source must be compared with 
published dose rate values for a similar source or with manually calculated values using the 
Sievert integral. Additional tests may include summing of the dose for multiple sources and 
the check of decay corrections with a proper choice of units. 
• Source Tests 
An important topic to be considered is the check of a new incoming source that is usually 
changed 3-4 times a year, its comparison with the institutional data and the data provided 
by the manufacturer. 
• Wipe tests 
All sources that are maintained in a permanent inventory are required to be wipe-tested for 
any leakage of radiation. 
Radiation levels should be measured and recorded both at the surface and at a 1-m distance. 
Individual encapsulated sources should be wipe-tested for possible leakage or contamination. 
A source is considered to be leaking if ~200 Bq (~5 nCi) of removable contamination using a 
cotton swab is measured in a GM counter or a scintillation well counter. 
• Calibration process and its metrological traceability 
Due to still some unresolved issues regarding the absolute standardization of the calibration 
procedures of 192Ir HDR sources [15,16], several methods (using the interpolative approach) 
are still being used, though traceable to the calibration laboratories. [17]. 
 
 
Fig. 5. A typical well-type ionization chamber, including a tool to performs tests of source 
positioning within 0.3 mm, timer accuracy, and consistency of source activity 
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It is recommended that brachytherapy sources have their source strength calibrations 
traceable to a national standards laboratory by using a calibrated well-type ionization 
chamber such as the one shown in Fig. [18]  
The activity of all sources should be measured on receipt with a local well-type chamber and 
compared with the manufacturer’s certificate of source strength. In case it is above the 
tolerance level, another measuring system should be used until the reason for the deviation 
is fully explained. 
• Constancy check of a calibrated dosimeter 
The consistency of the response of the dosimetric system (electrometer, cable and chamber) 
may be checked by periodic measurement using a source with long half-life, such as 137Cs 
placed inside the chamber in a reproducible position. Alternatively, one may use a radiation 
beam from a Linac or a Cobalt teletherapy unit fixing the irradiation parameters such as 
field size, geometry, distance source to surface of chamber and number of MU. [16 ]. 
• Regular check of the source positioning. 
The source positioning the catheter is a very important control point before each treatment 
is conducted. A very simple device may be used with the dummy source as shown in Fig.   
 
 
Fig. 6. The source position ruler showing the source in a red circle 
• Regular checks of applicators 
The applicators are used with very high frequency and go through severe handling, 
cleaning and sterilization processes. 
 
 
Fig. 7. Typical Gyn intracavitary applicator ring type with an intrauterine tandem 
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Periodic inspection and radiographic evaluation of all applicators should be performed at 
some pre-established frequency as proposed by and described in Table 6.2 
 
Gynecological appliances Element to be tested Frequency 
Tandems Flange screws function 
Curvature  
Closure caps function 
Plastic sleeve and rod fit 
and slide 
Each use 
Each use 
Each use 
Each use 
Fletcher-type ovoids Source carrier function 
Integrity of welds 
Position of shields 
Identification markers 
Bridge integrity/thumb 
screws 
Each use 
Each use 
Semi-annually or after repair 
Each use 
Each use 
Tandem-based cylinders 
and tandem checks 
Flanges function 
Identification markers 
Cylinders fit snugly 
Each use 
Each use 
Each use 
Solid cylinders Source carriers function 
Closure caps function 
Each use 
Each use 
Intra luminal catheters Integrity 
Strength of tip 
Each use (after sterilization) 
Each use (after sterilization) 
Table 8. Quality control procedures for brachytherapy appliances 
8. Independent auditing 
Quality audits are now considered an essential component of a QC program, and there is a 
strong trend for these audits to become an operational requirement by the licensing 
authorities. The quality audit is a way of independently verify the correctness and 
effectiveness of an ongoing program. This may be performed by individuals with qualified 
proficiency or by an accredited organization or institution. The first program available was 
offered by the Radiological Physics Centre (RPC) [6,1], which has been funded by the 
National Cancer Institute (NCI) continuously since 1968 to provide quality auditing of 
dosimetry practices at institutions participating in NCI cooperative clinical trials. These 
services may or not include site visits when the discrepancies need to be resolved. Similar 
services are provided in Europe by the EQUAL, which is funded by ESTRO [7]. In Brazil, 
this activity is conducted by the LCR [8], and recently the IAEA promoted this conception 
worldwide as part of the QUATRO program [10]. 
Other institutions providing quality audits are the American College of Radiology and 
American College of Radiation Oncology. These two programs are more involved and 
include site visits to the radiation oncology department being reviewed [19,20,21,22 ].  
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9. Final remarks 
Brachytherapy is indeed a very important treatment modality of several of the malignant 
diseases that allows conformal treatment without complex technological involvement. 
Although the basic principles of brachytherapy have not changed much during the past 100 
years of radiotherapy, the advent of remote after-loading made brachytherapy more 
efficient for the patient and much safer for staff from the radiation protection point of view.  
In terms of human resources, brachytherapy treatment requires considerably more 
involvement than an average external beam patient.  
Quality control programs must be flexible to permit additional testing whenever it seems 
necessary following repair, observed equipment behavior or indications of problems during 
the regular quality control tests. To diminish treatment interruption due to non-regular 
interventions or additional quality control measurements, it is essential to maintain the test 
and measurement equipment in good order and subject this equipment to its own quality 
control program, as well as to have alternate equipment readily available. 
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